Providing market intelligence for more than 35 years

In The News

Pay TV Providers Hanging On With Online Partnerships

New research from Parks Associates shows that 21 percent of U.S. pay TV subscribers subscribe to an online video service through their pay TV provider, up from 10 percent a year ago.

The research firm attributes this jump to the increasing number of partnerships between pay TV and OTT providers, with operators such as Comcast adding support for Netflix in their set-top boxes.

Other insights from Parks Associates' new consumer study include:

• pay TV subscription rates dropped from 86 percent in 2015 to 77 percent in late 2017;

• 84 percent of pay TV subscribers have service from a traditional cable, satellite or telco provider; and

• nearly 18 percent of pay TV households have a subscription package from an online video service, e.g., Sling, or a traditional provider now offering an online video bundle.

From the article "Pay TV Providers Hanging On With Online Partnerships."

Previously In The News

Cord-Cutting On The Rise In The US

“Pay TV subscriptions have dropped each year since 2014, falling to 81% of US broadband households in Q3 2016,” said Brett Sappington, senior director of research, Parks Associates. “Several factor...

OTT churn increases in US during pandemic

According to Parks Associates, an increasing number of US broadband households cancelled at least one OTT subscription in the early part of the year, with a significant number also utilising the free...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...